Breastcancer risk in families with mutations in PalB2, N Engl J Med, vol.371, pp.497-506, 2014. ,
chenevix-trench g, rahman n, robson M, Domchek SM, Foulkes WD. gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-57, 2015. ,
ellisen lW. clinical actionability of Multigene Panel testing for Hereditary Breast and Ovarian cancer risk assessment, JAMA Oncol, vol.1, pp.943-51, 2015. ,
time to incorporate germline multigene panel testing into breast and ovarian cancer patient care, Breast Cancer Res Treat, vol.160, pp.393-410, 2016. ,
nccn guidelines insights: genetic/Familial High-risk assessment: Breast and Ovarian, Version 2, Journal of the National Comprehensive Cancer Network, vol.15, pp.9-20, 2017. ,
Spurdle aB, gómez-garcía eB. enigMa clinical Working group. Brca1 and Brca2 genetic testingpitfalls and recommendations for managing variants of uncertain clinical significance, Ann Oncol, vol.26, pp.2057-65, 2015. ,
acMg laboratory Quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of Medical genetics and genomics and the association for Molecular Pathology, Genet Med, vol.17, pp.405-428, 2015. ,
Spurdle aB, radice P, De la Hoya M. kconFaB investigators. comprehensive annotation of splice junctions supports pervasive alternative splicing at the Brca1 locus: a report from the enigMa consortium, Hum Mol Genet, vol.23, pp.3666-80, 2014. ,
Spurdle aB, radice P, de la Hoya M. kconFaB investigators. naturally occurring Brca2 alternative mrna splicing events in clinically relevant samples, J Med Genet, vol.53, pp.548-58, 2016. ,
de la Hoya M. alternative splicing and molecular characterization of splice site variants: Brca1 c.591c>t as a case study, Clin Chem, vol.56, pp.53-61, 2010. ,
Spurdle aB. combined genetic and splicing analysis of Brca1 c, Hum Mol Genet, vol.25, pp.2256-68, 2016. ,
Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer, Eur J Hum Genet, vol.25, pp.1147-54, 2017. ,
, Human gc-ag alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions, Nucleic Acids Res, vol.29, pp.2581-93, 2001.
Different levels of alternative splicing among eukaryotes, Nucleic Acids Res, vol.35, pp.125-156, 2007. ,
, Nature, vol.489, pp.101-109, 2012.
alternative splicing: new insights from global analyses, Cell, vol.126, pp.37-47, 2006. ,
Most alternative isoforms are not Functionally important, Trends Biochem Sci, vol.42, pp.408-418, 2017. ,
the relationship between alternative Splicing and Proteomic complexity, Trends Biochem Sci, vol.42, pp.407-415, 2017. ,
rethinking gene regulatory networks in light of alternative splicing, intrinsically disordered protein domains, and posttranslational modifications, Front Cell Dev Biol, vol.3, p.8, 2015. ,
, Clin Chem, vol.60, pp.341-52, 2014.
Brown Ma, chenevix-trench g, Spurdle aB, Southey Mc. kconFab. Molecular characterization and cancer risk associated with Brca1 and Brca2 splice site variants identified in multiple-case breast cancer families, Hum Mutat, vol.26, p.495, 2005. ,
correlations between mutation site in aPc and phenotype of familial adenomatous polyposis (FaP): a review of the literature, Crit Rev Oncol Hematol, vol.61, pp.153-61, 2007. ,
exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes, Clin Genet, vol.88, pp.533-574, 2015. ,
PalB2: the hub of a network of tumor suppressors involved in Dna damage responses, Biochim Biophys Acta, vol.1846, pp.263-75, 2014. ,
Harrow J. the origins, evolution, and functional potential of alternative splicing in vertebrates, Mol Biol Evol, vol.28, pp.2949-59, 2011. ,
Stankovic t, taylor aM. a Hypomorphic PalB2 allele gives rise to an Unusual Form of Fa-n associated with lymphoid tumour Development, PLoS Genet, vol.12, p.1005945, 2016. ,